Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set - Joanna Tieu, Jonathan Tl Cheah, Rachel J. Black, Robin Christensen, Nilasha Ghosh, Pamela Richards, Joanna Robson, Beverley Shea, Lee S. Simon, Jasvinder A. Singhi, Peter Tugwell, Maarten Boers, Marco A. Alba Garibay, Corrado Campochiaro, Simon Decary - Dissemin

Language
Login

Published in

Elsevier, Seminars in Arthritis and Rheumatism, 5(51), p. 1139-1145, 2021

DOI: 10.1016/j.semarthrit.2021.06.010

Links

Tools

Export citation

Search in Google Scholar

Improving benefit-harm assessment of glucocorticoid therapy incorporating the patient perspective: The OMERACT glucocorticoid core domain set

Journal article published in 2021 by Joanna Tieu, Jonathan Tl Cheah, Rachel J. Black, Robin Christensen, Nilasha Ghosh, Pamela Richards, Joanna Robson, Beverley Shea, Lee S. Simon, Jasvinder A. Singhi, Peter Tugwell, Maarten Boers, Marco A. Alba Garibay, Corrado Campochiaro, Simon Decary and other authors.

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle

Preprint: archiving allowed

Upload

Orange circle

Postprint: archiving restricted

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO